Geron GERN

Geron Corp · Nasdaq · Pharmaceutical Preparations

$0.97-15.78%close on Oct. 28, 2026 · volume 81.7M · Yahoo Finance

Price, last 47 sessions

$1.00$1.20$1.40Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $1.59 · low $0.97 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 6 →
  • 8-KOct. 28, 2026, 4:47 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedGeron Corporation Discontinues Phase 3 IMpactMF Trial of Imetelstat After DMC Says Primary Overall Survival Endpoint Unlikely to Be Met

  • 4Oct. 1, 2026, 4:30 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 4:43 p.m. ETView on SEC.gov
  • SCHEDULE 13GAug. 7, 2026, 9:41 a.m. ETView on SEC.gov
  • 8-KAug. 6, 2026, 6:05 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • 10-QAug. 5, 2026, 4:41 p.m. ETView on SEC.gov